Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCellular and Molecular

Pharmacological Activation of Thermo–Transient Receptor Potential Vanilloid 3 Channels Inhibits Hair Growth by Inducing Cell Death of Hair Follicle Outer Root Sheath

Kangjiao Yan, Xiaoying Sun, Gongxin Wang, Yani Liu and KeWei Wang
Journal of Pharmacology and Experimental Therapeutics August 2019, 370 (2) 299-307; DOI: https://doi.org/10.1124/jpet.119.258087
Kangjiao Yan
Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoying Sun
Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gongxin Wang
Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yani Liu
Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KeWei Wang
Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Functional expression of TRPV3 proteins in mouse skin keratinocytes and ORS cells of hair follicles. (A) Left panel, Western blot analysis of TRPV3 proteins in human outer root sheath cells, dorsal skin of C57BL/6 mice, and HEK293/TRPV3 stably expressing the TRPV3 as positive controls, and untransfected HEK293 cells as negative control. Right panel, whole-cell patch clamp recordings of HEK293 cells overexpressing hTRPV3 in response to carvacrol alone (300 μM, red bar) or coapplication of 100 μM forsythoside B (blue bar). (B) Immunohistochemistry staining of TRPV3 proteins in mouse skin keratinocytes and hair follicles. Scale bar, 100 μm. (C) TRPV3 current in ORS cells was activated by 300 μM carvacrol (red bar) and inhibited by coapplication of 100 μM forsythoside B (blue bar). The right panel shows current-voltage curves of hTRPV3 channel in response to voltage ramps from −100 to +100 mV before (1), and after 300 μM carvacrol (2), and coaddition of 300 μM carvacrol and 100 μM forsythoside B (3), and washout (4).

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Inhibition of TRPV3 by forsythoside B attenuates carvacrol-induced ORS cell death. (A) Measurement of cell death for ORS cells before and after treatment of agonist carvacrol in different concentrations for 12 hours in cell death assay. Scale bar, 100 μm. (B) Summary from (A) for cell death ratio before and after treatment of carvacrol in different concentrations (N.S., no significance; **P < 0.01; ****P < 0.0001, by one-way ANOVA, followed by Dunnett’s test). (C) Measurement of cell death for ORS cells before and after treatment of carvacrol (300 μM) and different concentrations of forsythoside B for 12 hours in cell death assay. Scale bar, 100 μm. (D) Summary of (C) for cell death ratio after treatment of carvacrol (300 μM) and forsythoside B in different concentrations. Data are presented as the mean ± S.D. (N.S., no significance, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, by one-way ANOVA, followed by Dunnett’s test.) (E) Western blot analysis of TRPV3 proteins in ORS cells and ORS cells transfected with TRPV3 shRNA. (F) ORS cells and ORS cells transfected with TRPV3 shRNA were treated with 300 μM carvacrol for 24 hours. Cell viability was determined by colorimetric MTT cell viability assay. Data are presented as the mean ± S.D. [n = 6, ****P < 0.0001, by Student’s t test (unpaired).]

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Pharmacological activation of TRPV3 by carvacrol inhibits hair growth. (A) Top panel, a schematic drawing for generation of TRPV3 agonist carvacrol-induced hair growth inhibition in C57BL/6 mice. Bottom panel, mice (7–8 weeks) were shaved and given different compounds topically once a day until hair grew out, images of hair growth were recorded every 3 days. Scale bar, 500 μm. (B) Summary from (A) for hair length randomly plucked and measured (n = 8) at different time intervals (9, 12, 15, 18, and 21 day) after topical application of different concentrations of TRPV3 agonist carvacrol (Car) and antagonist forsythoside B. Data are presented as the mean ± S.D. (****P < 0.0001, by two-way ANOVA, followed by Dunnett’s test.) (C) A self-comparison group between the left and right side of the skin after topical application of 191.1 mM carvacrol and vehicle (50% ethanol), respectively, once a day, and images for hair growth were recorded every 3 days. Scale bar, 500 μm. (D) Summary from (C) for comparison of hair length randomly plucked (n = 8) between left (L) and right (R) side of the skin. Data are presented as the mean ± S.D. (****P < 0.0001, by two-way ANOVA, followed by Sidak’s test.)

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Inhibition of TRPV3 by forsythoside B attenuates carvacrol-induced hair growth inhibition in mice. (A) Top panel, a schematic drawing for generation of TRPV3 agonist carvacrol-induced hair growth inhibition and treatment with FB in C57BL/6 mice. In bottom panel, mice (7–8 weeks) were shaved and intradermal injections of forsythoside B in different concentrations (0.3, 1, 3 mM in 50 μl) into the dorsal area of skin 30 minutes before topical application of carvacrol (63.7 mM) once a day until hair grew out, images were recorded every 3 days. Scale bar, 500 μm. (B) Summary from (A) for hair length randomly plucked and measured (n = 8) at different time intervals (9, 12, 15, 18, and 21 day) after topical application or coapplication of different concentrations of TRPV3 agonist carvacrol (Car) and antagonist forsythoside B. Data are presented as the mean ± S.D. (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, by two-way ANOVA, followed by Dunnett’s test.)

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Activation of TRPV3 decreases hair follicles, and inhibition of TRPV3 prevents loss of hair follicles induced by carvacrol. (A) Transverse sections (top two rows) and longitudinal sections (bottom row) of dorsal skin tissues were stained with H&E before and after topical application of TRPV3 inhibitor forsythoside B alone or activator carvacrol (Car) in 63.7 or 191.7 mM or combination of Car and FB once a day. Scale bar, 100 μm. The skin tissue sections were prepared on day 10 after shaving. Representative images of skin tissue sections in each group were from eight mice. (B) Summary from (A) for the number of hair follicles before and after topical applications of TRPV3 modulators (carvacrol or forsythoside B) or combination. Data are presented as the mean ± S.D. (N.S., no significance, *P < 0.05; **P < 0.01; ***P < 0.001, by one-way ANOVA followed by Bonferroni’s test.)

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    A proposed mechanism underlying the death for hair follicle ORS cells and hair loss by TRPV3 activation. TRPV3 channels are expressed in the hair follicle ORS cells. Activation of TRPV3 channel by agonist carvacrol or gain-of-function mutation causes an excessive Ca2+ influx that induces ORS cell death via activation of unidentified Ca2+-dependent kinase. Overactive TRPV3 either by carvacrol (or gain-of-function mutations) causes a time- and dose-dependent reduction of hair shaft elongation and a decrease in hair follicles Probably through the induction of ORS cell death in hair follicles, thus leading to inhibition of hair growth. Pharmacological inhibition of overactive TRPV3 by forsythoside B can reverse hair loss.

Tables

  • Figures
    • View popup
    TABLE 1

    Pharmacological activation of TRPV3 by carvacrol causes delay of hair growth in mice Mean ± S.D. n = 8.*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, by one-way ANOVA, followed by Dunnett’s test

    GroupTime for Pink Skin Turning to BlackTime for Black Skin to Hair GrowthTime to Full Hair Growth
    DayDayDay
    Control8.0 ± 0.63.0 ± 0.59.0 ± 0.4
    50% Ethanol8.0 ± 0.63.0 ± 0.79.0 ± 0.6
    0.3 mM FB7.0 ± 0.42.0 ± 0.58.0 ± 0.6
    19.1 mM Car9.0 ± 0.94.0 ± 0.79.0 ± 0.6
    63.7 mM Car10.0 ± 1.2**4.0 ± 0.8*10.0 ± 0.9
    191.1 mM Car11.0 ± 1.8****5.0 ± 0.9***10.0 ± 1.1**
    • View popup
    TABLE 2

    Reversal of TRPV3 agonist carvacrol-induced inhibition of hair growth by inhibitor forsythoside B Mean ± S.D. n = 8.*p < 0.05, by one-way ANOVA, followed by Dunnett’s test

    GroupTime for Pink Skin to BlackTime for Black Skin to Hair GrowthTime to Full Growth of Hair
    DayDayDay
    63.7 mM Car10.0 ± 0.94.0 ± 0.710.0 ± 1.0
    Car + 0.3 mM FB9.0 ± 1.84.0 ± 0.710.0 ± 1.1
    Car + 1.0 mM FB9.0 ± 1.24.0 ± 0.69.0 ± 0.8
    Car + 3.0 mM FB7.0 ± 0.7*3.0 ± 0.5*9.0 ± 0.6
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 370 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 370, Issue 2
1 Aug 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacological Activation of Thermo–Transient Receptor Potential Vanilloid 3 Channels Inhibits Hair Growth by Inducing Cell Death of Hair Follicle Outer Root Sheath
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCellular and Molecular

Activation of TRPV3 Inhibits Hair Growth

Kangjiao Yan, Xiaoying Sun, Gongxin Wang, Yani Liu and KeWei Wang
Journal of Pharmacology and Experimental Therapeutics August 1, 2019, 370 (2) 299-307; DOI: https://doi.org/10.1124/jpet.119.258087

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCellular and Molecular

Activation of TRPV3 Inhibits Hair Growth

Kangjiao Yan, Xiaoying Sun, Gongxin Wang, Yani Liu and KeWei Wang
Journal of Pharmacology and Experimental Therapeutics August 1, 2019, 370 (2) 299-307; DOI: https://doi.org/10.1124/jpet.119.258087
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Nitrogen Mustard-Induced Ocular Toxicity
  • Effect of CBG and EAA on UVA-Irradiated Keratinocytes
  • Detecting Cancer-Immune Intercellular Interactions
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics